Jingyou Yu

Featured in: Favicon

nature.com Favicon

science.org Favicon

biorxiv.org Favicon

journals.plos.org Favicon

Articles

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection - Signal Transduction and Targeted Therapy

Jul 18, 2024 | nature.com | Xuan He |Jingyou Yu

Dear Editor,Due to the ongoing evolution of SARS-CoV-2 and waning immunity following COVID-19 vaccination, breakthrough infections have become common occurrences.
Ad26.COV2.S and SARS-CoV-2 Spike Protein Ferritin Nanoparticle Vaccine Protect Against SARS-CoV-2 Omicron BA.5 Challenge in Macaques

Mar 26, 2023 | cell.com | Jingyou Yu |Paul Thomas |Michaela Sciacca

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines demonstrate reduced protection against acquisition of BA.5 subvariant but still effective against severe disease. However, immune correlates of protection against BA.5 remain unknown.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →